Royalty Pharma
RPRX
RPRX
375 hedge funds and large institutions have $8.33B invested in Royalty Pharma in 2024 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 139 increasing their positions, 127 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% less funds holding
Funds holding: 376 → 375 (-1)
10% less capital invested
Capital invested by funds: $9.22B → $8.33B (-$885M)
Holders
375
Holding in Top 10
7
Calls
$13.5M
Puts
$4.19M
Top Buyers
| 1 | +$285M | |
| 2 | +$47.8M | |
| 3 | +$43.2M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$28M |
Top Sellers
| 1 | -$152M | |
| 2 | -$77.4M | |
| 3 | -$61.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.8M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$14.5M |